Use of Epstein-Barr Virus (EBV) Cytotoxic T Lymphocyte Therapy in a Kidney Transplant Recipient with EBV-Associated Smooth Muscle Tumors

被引:0
|
作者
Saranu, Rohan [1 ]
Babicz, Richard S. [1 ]
Jo, Vickie Y. [1 ]
Nikiforow, Sarah [2 ]
Chandraker, Anil K. [1 ]
机构
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PO2099
引用
收藏
页码:642 / 642
页数:1
相关论文
共 50 条
  • [21] Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease
    Gallagher, A
    Armstrong, AA
    MacKenzie, J
    Shield, L
    Khan, G
    Lake, A
    Proctor, S
    Taylor, P
    Clements, GB
    Jarrett, RF
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (04) : 442 - 448
  • [22] Epstein Barr Virus (EBV)- associated to Smooth Muscle Tumor (SMT) in a renal transplant recipient: Case Report.
    Salas, Paulina
    Pinto, Viola
    Sugg, Carolina
    Dinamarca, Hector
    Galvez, Carla
    Grandy, Jean
    Maldonado, Maria
    Iniguez, Rodrigo
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2342 - 2343
  • [23] Adoptive cell transfer of allogeneic Epstein-Barr virus-specific T lymphocytes for treatment of refractory EBV-associated post-transplant smooth muscle tumors: A case report
    Hansen, B. -T
    Bacher, P.
    Eiz-Vesper, B.
    Heckl, S. M.
    Klapper, W.
    Koch, K.
    Maecker-Kolhoff, B.
    Baldus, C. D.
    Fransecky, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 225 - 225
  • [24] Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection
    Kasahara, Y
    Yachie, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (03) : 283 - 294
  • [25] The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases
    Zhang, Linlin
    Wang, Ran
    Xie, Zhengde
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 106 (12) : 4413 - 4426
  • [26] Plasma Epstein-Barr virus (EBV) DNA as a tool for post-treatment monitoring of EBV-associated malignancies
    Lo, YMD
    BRITISH JOURNAL OF CANCER, 2002, 86 : S6 - S6
  • [27] Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy
    Mcmiller, Tracee L.
    Besharati, Sepideh
    Yarchoan, Mark
    Zhu, Qingfeng
    Unsal-Kacmaz, Keziban
    Xu, Ke
    Lee, Junghwa
    Bhaijee, Feriyl
    Engle, Logan L.
    Taube, Janis M.
    Berger, Alan E.
    Anders, Robert A.
    Topalian, Suzanne L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [28] Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report
    Hansen, Bjoern-Thore
    Bacher, Petra
    Eiz-Vesper, Britta
    Heckl, Steffen M.
    Klapper, Wolfram
    Koch, Karoline
    Maecker-Kolhoff, Britta
    Baldus, Claudia D.
    Fransecky, Lars
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [29] Immunophenotypic analysis of Epstein-Barr virus (EBV)infected CD8+ T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis
    Wada, Taizo
    Kurokawa, Toshiro
    Toma, Tomoko
    Shibata, Fumie
    Tone, Yumi
    Hashida, Yoko
    Kaya, Hiroyasu
    Yoshida, Takashi
    Yachie, Akihiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (01) : 72 - 75
  • [30] Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies
    Li, Hongde
    Hu, Jianmin
    Luo, Xiangjian
    Bode, Ann M.
    Dong, Zigang
    Cao, Ya
    CANCER SCIENCE, 2018, 109 (07): : 2101 - 2108